Medical News
August 10th, 2009
The US FDA recently issued a recommendation advising that certain pharmaceutical components used in the production or composition of drug products should be tested for melamine.
August 7th, 2009
The US FDA has advised healthcare practitioners and consumers of current safety information with regard to body building and increase muscle mass products, these products are commonly described as a substitute for anabolic steroids (used to increase muscle mass and strength), available both online and in retail establishments.
August 7th, 2009
The FDA’s laboratory analysis discovered sulfoaildenafil, an analog of sildenafil. Sildenafil is a key ingredient in the FDA-approved drug for erectile dysfunction, which makes Steam an unsanctioned drug.
August 7th, 2009
Baxter International has recently announced that they have finished the production of their first commerical batches of CELVAPAN A/H1N1 pandemic vaccine.
August 7th, 2009
The US FDA requires TNF blockers to include firm detailed warnings in the prescribing information.
August 7th, 2009
A recent Government report states that the foremost source of poisonings among American children can be located in the household medicine cabinet.
August 7th, 2009
The US FDA cautions consumers of the harmful effects Clarcon skin products are having on the skin. They urge consumers to cease all usage of Clarcon Biological Chemistry Laboratory skin sanitizer or protectants, because of hazardous bacteria.
August 7th, 2009
Biopharmaceutical company Insmed Inc. has publicized that effective immediately, they will halt new patient distribution of Iplex. They feel it is in the existing patients best interest to maintain supplies at this time for their treatment only. As a result, at this time, Insmed will not instigate further clinical trials of Iplex.
August 7th, 2009
The US FDA has announced and advised healthcare providers of modifications to the well-known drug names for Botox / Botox Cosmetics, Dysport and Myobloc. These modifications are in the hopes to provide healthcare professionals advice on how to avoid medication inaccuracy, and reinforce individual potency. The modifications are also to provide additional information to patients, family members and caregivers.
August 7th, 2009
Recently, the US FDA has approved a once-daily tablet to treat adult Type 2 Diabetes. Along with diet and exercise, Onglyza will assist to manage high blood sugar levels.
